Last reviewed · How we verify

NCT06823388

Assessment of Acupuncture on Eye Fatigue

Completed NA Last updated 18 December 2025
What this trial tests

NA trial testing acupuncture in Acupuncture in 30 participants. Completed in 30 May 2025.

Timeline
1 August 2024
Primary endpoint
30 December 2024
30 May 2025

Quick facts

Lead sponsorChung Shan Medical University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date1 August 2024
Primary completion30 December 2024
Estimated completion30 May 2025
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chung Shan Medical University

Who can join

18 and older, any sex, with Acupuncture or Eye Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to assess the effiacy of acupuncutre on eye fatigue. The indicator of eye fatigue is eye accommodation ability. Patients will be randomly assigned to the experimental group and the control group. The experimental group will receive acupuncture treatment, while the control group will receive sham acupuncture stimulation. The eye accommodation ability of both groups will be easured before and after the intervention, and the differences in eye accommodation ability before and after treatment will be analyzed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

Other recruiting trials for Acupuncture

Currently open trials in the same condition.

Other Chung Shan Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06823388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing